Actively Recruiting
Comparison of Standard vs. Accelerated Corneal Crosslinking
Led by Price Vision Group · Updated on 2025-07-31
510
Participants Needed
1
Research Sites
376 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.
CONDITIONS
Official Title
Comparison of Standard vs. Accelerated Corneal Crosslinking
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Documented keratoconus or ectasia after refractive surgery
You will not qualify if you...
- Insufficient corneal thickness
- Ocular condition that may predispose the eye to complications
- History of chemical injury or delayed epithelial healing
- Condition that would interfere with or prolong epithelial healing
- Known sensitivity to treatment medications
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Price Vision Group
Indianapolis, Indiana, United States, 46260
Actively Recruiting
Research Team
M
Marianne Price, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here